Procter & Gamble Health Limited — Others, 12-02-2025: Appointment

Mr. Sharad Tyagi has been appointed as a Non-Executive Independent Director of Procter & Gamble Health Limited for a five-year term starting April 1, 2025, pending shareholder approval. With extensive experience in the pharmaceutical and specialty chemicals industries, including leadership roles at Boehringer Ingelheim and Dr. Reddy’s, he brings valuable strategic and operational expertise. This appointment could enhance governance and oversight within the company. Investor sentiment may lean positive, given Mr. Tyagi’s proven track record in business development and change management, which could signal robust future growth potential.